Hypofractionated high-dose intensity-modulated radiotherapy
This is an experimental form of intensity-modulated radiotherapy where higher X-ray dosages are used in fewer fractions (sessions) this is called hypofractionated radiotherapy. Although the dose per fraction is higher than standard radiotherapy, the total dose is lower.[1]
The hope is that it will be as effective but cause less toxicity.[1]
Prostate cancer[edit | edit source]
One trial[2] for prostate cancer ran in 2011.[1]In 2016 the HYPRO study reported results comparing the use of standard fractionation (39 fractions of 2 Gy for 8 weeks) with hypofractionation (with 19 fractions of 3.4 Gy for 6.5 weeks) among 820 patients with intermediate- or high-risk prostate cancer.[3]
References[edit | edit source]
- ↑ 1.0 1.1 1.2 "A trial comparing different ways of giving radiotherapy for prostate cancer (CHHIP)". 2015-03-17.
- ↑ UKCRN Database:Conventional or Hypofractionated High Dose Intensity Modulated Radiotherapy for Prostate Cancer Archived September 27, 2007, at the Wayback Machine
- ↑ Toxicities May Affect Readiness of Hypofractionation in Prostate Cancer. March 2016
 | This oncology article is a stub. You can help WikiMD by expanding it. |
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Prab R. Tumpati, MD
